Acumen Pharmaceuticals Stock Widgets and Gadgets
ABOS Stock | USD 2.37 0.06 2.60% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ABOS Acumen Pharmaceuticals
- Latest Acumen Pharmaceuticals, Inc. Q3 2024 Earnings Call Transcript
- ABOS 2.37 0.06
- Low 2.26
- High 2.38
- Alpha -0.52
- Beta 2.98
- Return On Equity -0.33
- Return On Asset -0.21
- Current Valuation (29.49 M)
- Shares Outstanding 60.08 M
- Shares Owned By Insiders 11.23 %
- Shares Owned By Institutions 78.48 %
- Number Of Shares Shorted 1.45 M
- Price To Book 0.66 X
- Price To Sales 538.78 X
- Gross Profit (32.36 M)
- EBITDA (51.61 M)
- Net Income (52.37 M)
- Cash And Equivalents 189.91 M
- Cash Per Share 4.69 X
- Total Debt 28.49 M
- Current Ratio 37.21 X
- Book Value Per Share 3.62 X
- Cash Flow From Operations (43.06 M)
- Short Ratio 7.19 X
- Earnings Per Share (1.38) X
- Price To Earnings To Growth (0.23) X
- Target Price 10.8
- Number Of Employees 51
- Beta 0.039
- Market Capitalization 142.39 M
- Total Asset 310.12 M
- Retained Earnings (222.8 M)
- Working Capital 233.64 M
- Net Asset 310.12 M
- Accumulation Distribution 0.0504
- Daily Balance Of Power 0.5
- Rate Of Daily Change 1.03
- Day Median Price 2.32
- Day Typical Price 2.34
- Market Facilitation Index 0.12
- Price Action Indicator 0.08
- Period Momentum Indicator 0.06
- Relative Strength Index 77.11
Market Snapshot Widget Example
DAX Index Germany | 19,323 0.92 | |
Taiwan Weighted Taiwan | 22,904 1.55 | |
PSI 20 Stock Portugal | 6,409 0.76 | |
CROBEX Croatia | 3,118 0.21 | |
Budapest SE Hungary | 79,552 0.41 | |
IDX 30 Jakarta Indonesia | 448.67 1.38 | |
ISEQ 20 Price Ireland | 1,611 0.16 | |
NYSE Comp USA | 20,123 0.78 | |
Tel Aviv 35 Israel | 2,260 0.33 | |
Coreshares Index Tracker South Afric | 1,101 1.57 | |
IPC MEXICO Mexico | 50,437 0.01 | |
KL Technology Malaysia | 59.16 0.08 | |
IBEX 35 Index Spain | 11,657 0.39 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,533 0.22 | |
SPASX Dividend Opportunities Australia | 1,702 1.08 | |
HNX 30 Vietnam | 467.97 0.39 | |
Bucharest BET-NG Romania | 1,220 0.53 | |
AMS Small Cap Netherlands | 1,183 0.81 | |
Oslo Exchange Mutual Norway | 1,422 0.44 | |
BEL Small Belgium | 8,105 0.52 | |
Basic Materials Brazil | 5,762 1.29 | |
Swiss Leader Price Switzerland | 1,932 1.11 | |
Fondo Mutuo ETF Chile | 1,374 0.04 | |
Athens General Comp Greece | 1,402 0.28 | |
Stock Exchange Of Thailand | 1,446 0.41 | |
PX Prague Stock Czech Repub | 1,697 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,780 1.21 | |
WIG 30 Poland | 2,814 0.77 | |
BIST Electricity Turkey | 489.48 1.78 |
Investing Ideas
In addition to having Acumen Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Acumen Pharmaceuticals
Compare Acumen Pharmaceuticals To Peers
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.